Stage_I_and_II_subdiaphragmatic_Hodgkin's_disease._From_January_1971_to_December_1986,_521_patients_with_Hodgkin's_disease_were_evaluated_and_treated_at_the_Yale_University_School_of_Medicine_or_one_of_its_close_affiliates._A_total_of_258_patients_had_pathologic_stage_(PS)_I_or_II_disease,_with_239_patients_having_Hodgkin's_disease_above_the_diaphragm_(ADHD)_and_19_patients_having_Hodgkin's_disease_below_the_diaphragm_(BDHD)._A_comparison_of_patients_with_BDHD_versus_patients_with_ADHD_showed_that_patients_with_BDHD_were_older_(mean_age,_42_versus_28_years_of_age,_P_=_0.005),_were_initially_seen_less_often_with_nodular_sclerosis_subtype_(32%_versus_77%,_P_=_0.00001),_and_had_a_higher_male:_female_ratio_(2.8_versus_1.2,_P_=_0.12)._Ten_patients_with_BDHD_(53%)_had_positive_findings_at_staging_laparotomy_(0_of_4_clinical_stage_CS_IA_patients_and_10_of_15_(67%)_CS_II_patients)._Radiation_therapy_alone_was_the_initial_treatment_of_choice_for_74%_of_patients_with_BDHD_versus_94%_of_the_patients_with_ADHD._There_was_no_statistical_difference_in_the_overall_survival_or_relapse-free_survival_rates_for_patients_with_BDHD_versus_ADHD_(10-year_survival_rates,_BDHD_=_73%_and_ADHD_=_81%)._However,_patients_with_BDHD_who_initially_had_intra-abdominal_disease_had_a_statistically_significant_increase_in_death_rate_(60%)_due_to_Hodgkin's_disease_compared_with_patients_with_BDHD_who_initially_had_only_peripheral_nodal_disease_(0%)._Treatment_recommendations_for_patients_with_BDHD_should_be_tailored_to_the_specific_clinical_presentation_of_each_patient._For_most_PS_IA/IIA_patients_initially_seen_with_peripheral_nodal_disease,_radiation_therapy_alone_is_a_successful_treatment_program._However,_combined_modality_therapy_should_be_the_treatment_of_choice_for_patients_with_BDHD_initially_seen_with_intra-abdominal_disease.